Translational research to develop a human pbpk models tool kit-volatile organic compounds (VOCS)

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 75, Issue 1, 2012, Pages 6-24

  Mumtaz, M Moiz ^a   Ray, Meredith ^b   Crowell, Susan R ^c   Keys, Deborah ^d   Fisher, Jeffrey ^e   Ruiz, Patricia ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; CARBON TETRACHLORIDE; DICHLOROMETHANE; TETRACHLOROETHYLENE; TRICHLOROETHYLENE; VINYL CHLORIDE; VOLATILE ORGANIC COMPOUND;

ACCURACY; ARTICLE; BLOOD LEVEL; CALCULATION; COMPUTER LANGUAGE; COMPUTER MODEL; COMPUTER SIMULATION; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HUMAN; POLLUTANT; PREDICTION; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; TOXICITY TESTING; TRANSLATIONAL RESEARCH; UNITED STATES;

COMPUTER SIMULATION; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; EPIDEMIOLOGIC STUDIES; HUMANS; MODELS, BIOLOGICAL; PUBLIC HEALTH; RESEARCH DESIGN; RISK ASSESSMENT; UNITED STATES; VOLATILE ORGANIC COMPOUNDS;

ANIMALIA;

EID: 81255169219     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2012.625546     Document Type: Article

References (60)

1. Andersen, M. E. 1994. Physiologically based pharmacokinetics and cancer risk assessment. Environ. Health Perspect. 102:103-4.
2. Agency for Toxic Substances and Disease Registry. 1997a. Toxicological profile for perchloroethylene. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service.
3. Agency for Toxic Substances and Disease Registry. 1997b. Toxicological profile for trichloroethylene. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service.
4. Agency for Toxic Substances and Disease Registry. 2000. Toxicological profile for dichloromethane. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service.
5. Agency for Toxic Substances and Disease Registry. 2005. Toxicological profile for carbon tetrachloride. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service.
6. Agency for Toxic Substances and Disease Registry. 2006. Toxicological profile for vinyl chloride. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service.
7. Agency for Toxic Substances and Disease Registry. 2007. Toxicological profile for benzene. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service.
8. Bailer, A. J. 1997. An introduction to the use of physiologically based pharmacokinetic models in risk assessment. Stat. Methods Med. Res. 6:341-58.
9. Blaauboer, B. J. 2003. The integration of data on physico-chemical properties, in vitroderived toxicity data and physiologically based kinetic and dynamic as modelling a tool in hazard and risk assessment. A commentary. Toxicol. Lett. 138:161-71.
10. Bogen, K. T., and T. E. McKone. 1988. Linking indoor air and pharmacokinetic models to assess tetrachloroethylene risk. Risk Anal. 8:509-20.
11. Blaauboer, B. J. 2010. Biokinetic modeling and in vitro-in vivo extrapolations. J. Toxicol. Environ. Health B Crit. Rev. 13(2):242-52
12. Brown, E. A., M. L. Shelley, and J. W. Fisher. 1998. A pharmacokinetic study ofoccupational and environmental benzene exposure with regard to gender. Risk Anal. 18:205-13.
13. Brown, R. P., M. C. Delp, S. L. Lindstedt, L. R. Rhomberg, and R. P. Beliles. Physiological parameter values for physiologically based pharmacokinetic models. 1997. Toxicol. Ind. Health 13:407-84.
14. Centers for Disease Control and Prevention. 2009. Fourth national report on human exposure to environmental chemicals. Atlanta, GA: National Center for Environmental Health, Division of Laboratory Sciences. Available at: http://www.cdc.gov/ exposurereport (accessed February 28, 2011).
15. Clewell, H. J., and M. E. Andersen. 1996. Use of physiologically based pharmacokinetic modeling to investigate individual versus population risk. Toxicology 111:315-29.
16. Clewell, H. J., M. E. Andersen, and B. J. Blaauboer. 2008. On the incorporation of chemical-specific information in risk assessment. Toxicol. Lett. 180:100-9.
17. Clewell, H. J., P. R. Gentry, J. E. Kester, and M. E. Andersen. 2005. Evaluation of physiologically based pharmacokinetic models in risk assessment: An example with perchloroethylene. Crit. Rev. Toxicol. 35:413-33.
18. Clewell, H. J., P. R. Gentry, J. M. Gearhart, B. C. Allen, and M. E. Andersen. 2001a. Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. Sci. Total Environ. 274:37-66.
19. Clewell, H. J., P. R. Gentry, J. M. Gearhart, T. R. Covington, M. I. Banton, and M. E. Andersen. 2001b. Development of a physiologically based pharmacokinetic model of lsopropanol and its metabolite acetone. Toxicol. Sci. 63:160-72.
20. Clewell, H. J., P. R. Gentry, T. R. Covington, and J. M. Gearhart. 2000. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ. Health Perspect. 108:283-305.
21. Clewell, H. J., Y. M. Tan, J. L. Campbell, and M. E. Andersen. 2008. Quantitative interpretation of human biomonitoring data. Toxicol. Appl. Pharmacol. 231:122-133.
22. Corley, R. A., S. M. Gordon, and L. A. Wallace. 2000. Physiologically based pharmacokinetic modeling of the temperaturedependent dermal absorption of chloroform by humans following bath water exposures. Toxicol. Sci. 53:13-23.
23. Covington, T. R., P. R. Gentry, C. B. Van Landingham, M. E. Andersen, J. E. Kester, and H. J. Clewell. 2007. The use of Markov chain Monte Carlo uncertainty analysis to support a public health goal for perchloroethylene. Regul. Toxicol. Pharmacol. 47:1-18.
24. Cowles, A. L., H. H. Borgstedt, and A. J. Gillies. 1971. Tissue weights and rates of blood flow in man for the prediction of anesthetic uptake and distribution. Anesthesiology 3:523-26.
25. David, R. M., H. J. Clewell, P. R. Gentry, T. R. Covington, D. A. Morgott, and D. J. Marino. 2006. Revised assessment of cancer risk to dichloromethane II: Application of probabilistic methods to cancer risk determinations. Regul. Toxicol. Pharmacol. 45:55-65.
26. De Buck, S. S., and C. E. Mackie. 2007. Physiologically based approaches towards the prediction of pharmacokinetics: In vitro- in vivo extrapolation. Expert Opin. Drug Metab. Toxicol. 3(6):865-78.
27. Delic, J. I., P. D. Lilly, A. J. MacDonald, and G. D. Loizou. 2000. The utility of PBPK in the safety assessment of chloroform and carbon tetrachloride. Regul. Toxicol. Pharmacol.. 32:144-55.
28. Dennison, J. E., P. L. Bigelow, M. M. Mumtaz, M. E. Andersen, I. D. Dobrev, and R. S.Yang. 2005. Evaluation of potential toxicity from co-exposure to three CNS depressants (toluene, ethylbenzene, and xylene) under resting and working conditions using PBPK modeling. J. Occup. Environ. Hyg. 2: 127-35.
29. Dobrev, I. D., M. E. Andersen, and R. S. H. Yang. 2002. In silico toxicology: Simulating interaction threshold for human exposure to mixtures of trichloroethylene, trichloroethane. Environ. Health Perspect. 110: 1031-1039.
30. El-Masri, H. A., M. M. Mumtaz, G. Choudhary, W. Cibulas, and C. T. De Rosa. 2002. Applications of computational toxicology methods at the Agency for Toxic Substances and Disease Registry. Int. J. Hyg. Environ Health 205:63-9.
31. Fisher, J., D. Mahle, L. Bankston, R. Greene, and J. Gearhart. 1997. Lactational transfer of volatile chemicals in breast milk. AIHA J. 58:425-531.
32. Fisher, J. W., D. Mahle, and R. Abbas. 1998. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichoroacetic acid and free trichloroethanol. Toxicol. Appl. Pharmacol. 152:339-59.
33. Forsby, A., and B. Blaauboer. 2007. Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation of in vivo neurotoxicity. Hum. Exp. Toxicol. 26:333-38.
34. Grab It!TM XP2. 1998-2001. Raleigh, NC: Datatrend Software.
35. Haddad, S., G. Charest-Tardif, and K. Krishnan. 2000. Physiologically based modeling of the maximal effect of metabolic interaction on the kinetics of components of complex chemical mixtures. J. Toxicol. Environ. Health A 61:209-23.
36. International Commission on Radiological Protection. 2007. The ICRP reference manual, 103. Oxford: ICRP.
37. Kamgang, E., T. Peyret, and K. Krishnan. 2008. An integrated QSPR-PBPK modeling approach for in vitro-in vivo extrapolation of pharmacokinetics in rats. SAR QSAR Environ. Res. 19:669-80.
38. Keys, D. A., J. V. Bruckner, S. Muralidhara, and J. W. Fisher. 2003. Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic modelsfor trichloroethylene. Toxicol. Sci. 76: 35-50.
39. Krishnan, K., S. Haddad, M. Béliveau, and R. Tardif. 2002. Physiological modeling and extrapolation of pharmacokinetic interactions from binary to more complex chemical mixtures. Environ. Health Perspect. 110: 989-94.
40. Louisse J., E. de Jong, J. J. van de Sandt, B. J. Blaauboer, R. A. Woutersen, A. H. Piersma, I. M. Rietjens, and M. Verwei. 2010. The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man. Toxicol. Sci. 118:470-84.
41. Macey, R. I., and G. F. Oster. 1996-2006. Berkeley Madonna. Version 8.3.9. Berkeley: University of California at Berkeley.
42. McKone, T. E. 1993. Linking a PBPK model for chloroform with measured breath concentrations in showers: implications for dermal exposure models. J. Expos. Anal. Environ. Epidemiol. 3:339-65
43. Mumtaz, M. M., L. A. Knauf, D. J. Reisman, W. B. Peirano, C. T. De Rosa, V. K. Gombar, K. Enslein, J. R. Carter, B.W. Blake, K. I. Haque, and V. M. S. Ramanajum. 1995. Assessment of effect levels of chemicals from quantitative structure-activity relationship (QSAR) models. Toxicol. Lett. 79:131-43.
44. Peyret, T., and K. Krishnan. 2011. QSARs for PBPK modeling of environmental contaminants. SAR QSAR Environ. Res 22:129-69.
45. Poet, T. S., K. K.Weitz, R. A.Gies, J. A. Edwards, K. D Thrall, R. Corley, A. H Tanojo, X. Hui, H. I. Maibach, and R. C Wester. 2002. PBPK Modeling of the percutaneous absorption of perchloroethylene from a soil matrix in rats and humans. Toxicol. Sci. 67:17-31.
46. Poet, T. S., R. A. Corley, K. D. Thrall, J. A. Edward, H.Tanoho, K. K. Weitz, H. I. Maibach, and R. C. Wester. 2000. Assessment of the percutaneous absorption of trichloroethylene in rats and humans using MX/MX real-time breath analysis and physiologically based pharmacokinetic modeling. Toxicol. Sci. 56:42-51.
47. Price, K., and K. Krishnan. 2011. An integrated QSAR-PBPK modeling approach for predicting the inhalation toxicokinetics of mixtures of volatile organic chemicals in the rat. SAR QSAR Environ. Res 22:107-128.
48. Redding, L. E., M. D. Sohn, T. E. McKone, J. W. Chen, S. L. Wang, D. P. Hsieh, and R. S. H. Yang. 2008. Population physiologically based pharmacokinetic modeling for the human lactational transfer of PCB-153 with consideration of worldwide human biomonitoring results. Environ. Health Perspect. 116: 1629-1635.
49. Reddy, M., R. S. H. Yang, H. J. Clewell, and M. E. Andersen, eds. 2005. Physiologically based pharmacokinetic modeling. Hoboken, NJ: Wiley Interscience, JohnWiley & Sons.
50. Reitz, R. H., M. L. Gargas, M. E. Andersen, W. F. Provan, and T. Green. 1996. Predicting cancer risk from vinyl chloride exposure with a physiologically based pharmacokinetic model. Toxicol. Appl. Pharmacol. 137: 253-67.
51. Robson, M. G., and W. A. Toscano, eds. 2007. Risk assessment for environmental health. San Francisco: Jossey-Bass.
52. Ruiz, P., B. A. Fowler, J. D. Osterloh, J. Fisher, and M. Mumtaz. 2010a. Physiologically based pharmacokinetic (PBPK) tool kit for environmental pollutants-Metals. SAR QSAR Environ. Res. 21:603-18.
53. Ruiz, P., M. Mumtaz, and V. Gombar. 2010b. Assessing the toxic effects of ethylene glycol ethers using quantitative structure toxicity relationship models. Toxicol. Appl. Pharmacol. 254:198-205.
54. Ruiz, P., M. Mumtaz, J. Osterloh, J. Fisher, and B. A. Fowler. 2010c. Interpreting NHANES biomonitoring data, cadmium. Toxicol. Lett. 198:44-8.
55. Sohn, M. D., T. E. McKone, and J. Blancato. 2004. Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study. J. Expos. Anal. Environ. Epidemiol. 14: 204-13.
56. Tan, Y.-M., J. L., Campbell, and H. J. Clewell. 2007. Reverse dosimetry: Interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling. J. Expos. Anal. Environ. Epidemiol. 17:591-603.
57. Tan, Y.-M., K. H., Liao, R. B. Conolly, B. C. Blount, A. M. Mason, and H. J Clewell. 2006. Use of physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform. J. Toxicol. Environ. Health A 69: 1727-56.
58. Thomas, R. S., P. L. Bigelow, T. J. Keefe, and R. S. H. Yang. 1996. Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation. AIHA J. 57:23-32.
59. Thrall, K. D., M. E. Vucelick, R. A. Gies, R. C. Zangar, K. K. Weitz, T. S. Poet, D. L. Springer, D. M. Grant, and J. M. Benson. 2000. Comparative metabolism of carbon tetrachloride in rats, mice, and hamsters using gas uptake and PBPK modeling. J. Toxicol. Environ. Health A 60:531-48.
60. Yokley, K., H. T. Tran, K. Pekari, S. Rappaport, V. Riihimaki, N. Rothman, S. Waidyanatha, and P. M. Schlosser. 2006. Physiologicallybased pharmacokinetic modeling of benzene in humans: A Bayesian approach Risk Anal. 26:925-43.